These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29949618)

  • 1. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
    PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.
    Xu D; Su C; Guo L; Yan H; Wang S; Yuan C; Chen G; Pang L; Zhang N
    Open Life Sci; 2019 Jan; 14():275-287. PubMed ID: 33817161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
    Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
    Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis.
    Liu X; Su C; Xu J; Zhou D; Yan H; Li W; Chen G; Zhang N; Xu D; Hu H
    Oncol Lett; 2019 Feb; 17(2):2308-2316. PubMed ID: 30675296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
    Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
    Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
    Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
    Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
    Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
    Dobrescu R; Picu C; Caragheorgheopol A; Manda D; Ioachim D; Goldstein A; Badiu C
    Cancer Biomark; 2020; 29(3):337-346. PubMed ID: 32716342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
    Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
    Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
    [No Abstract]   [Full Text] [Related]  

  • 11. Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.
    Jianyong L; Zhihui L; Rixiang G; Jingqiang Z
    BMC Cancer; 2018 Apr; 18(1):390. PubMed ID: 29621982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer.
    Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Fanaei SA; Hedayati M; Azizi F
    BMC Cancer; 2018 Dec; 18(1):1199. PubMed ID: 30509240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Values of ultrasound features and MMP-9 of papillary thyroid carcinoma in predicting cervical lymph node metastases.
    Zhang Y; Luo YK; Zhang MB; Li J; Li CT; Tang J; Li JL
    Sci Rep; 2017 Jul; 7(1):6670. PubMed ID: 28751724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
    Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) - Why contrast-enhanced ultrasound (CEUS) was performed before thyroidectomy.
    Zhan J; Diao X; Chen Y; Wang W; Ding H
    Clin Hemorheol Microcirc; 2019; 72(1):61-73. PubMed ID: 30452407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinicopathological Features of Papillary Thyroid Carcinoma Patients with Positive Hepatitis B Surface Antigen.
    Zhong Z; Yuan J; Chen X; Chen Z; Du J; Chen Z; Kuang J; Cong S; Li J; Wu Z
    Oncol Res Treat; 2020; 43(1-2):27-33. PubMed ID: 31722345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1.
    Jianming L; Jibin L; Linxue Q
    Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
    Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
    PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.